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TRANSDERMAL DRUG DELIVERY: MICROFABRICATION INSIGHTS 
Ciprian Iliescu, Bangtao Chen, Jiashen Wei, Zhilian Yue 





Abstract–The paper presented an enhancement solution for 
transdermal drug delivery using microneedles array with 
biodegradable tips. The microneedles array was fabricated 
by using deep reactive ion etching (DRIE) and the 
biodegradable tips were made to be porous by 
electrochemical etching process. The porous silicon 
microneedle tips can greatly enhance the transdermal drug 
delivery in a minimum invasion, painless, and convenient 
manner, at the same time; they are breakable and 
biodegradable. Basically, the main problem of the silicon 
microneedles consists of broken microneedles tips during 
the insertion. The solution proposed is to fabricate the 
microneedle tip from a biodegradable material – porous 
silicon. The silicon microneedles are fabricated using DRIE 
notching effect of reflected charges on mask. The process 
overcomes the difficulty in the undercut control of the tips 
during the classical isotropic silicon etching process. When 
the silicon tips were formed, the porous tips were then 
generated using a classical electrochemical anodization 
process in MeCN/HF/H2O solution. The paper presents the 
experimental results of in vitro release of calcein and BSA 
with animal skins using a microneedle array with 
biodegradable tips. Compared to the transdermal drug 
delivery without any enhancer, the microneedle array had 
presented significant enhancement of drug release.  





Transdermal delivery is an attractive method to 
deliver drugs or biological compounds into 
human body, for its distinct advantage of 
eliminating pain and inconvenient intravenous 
injections. However, the efficiency of 
transdermal delivery is greatly limited by the 
poor permeability of the hard layer of skin at the 
stratum corneum (SC) which is the outmost layer 
of skin that forms the primary transport barrier 
[1]. The rate of transdermal drug diffusion also 
depends in part on the size and hydrophilicity of 
the drug molecules, which usually takes a long 
time, up to hours or days, and it may not be 
convenient or practical for clinical application. 
Due to this fact, only small doses (<10 mg/day) 
of lipophilic and low-molecular weight drugs (< 
500 Da) can be successfully delivered via 
transdermal method [2]. A number of methods 
have been developed in order to improve drug 
transport across the skin, methods that include 
mechanical [3] or chemical enhancers [4], 
iontophoresis [5], electroporation [6] and 
sonophoresis [7].  
The solid microneedle array, first reported by 
Henry et al in [8], was used as a mechanical 
enhancer to improve the drug penetration through 
the skin. In this technique, micro-sized needles 
protrude through the primary biological barrier of 
TDD, the stratum corneum, yet without affecting 
the dermis layer that contains nerves and blood 
vessels, thus avoiding pain and bleeding (shown 
in Figure 1). Moreover, the microneedle arrays 
have the advantage of a uniform delivery of the 
drug. Because these devices are fabricated using 
microfabrication technology, they can be easily 
scaled up for cheap and reproducible mass 
production. So far, a wide variety of microneedles 
fabricated from different materials has been 
reported. Arrays of hollow out-of-plane silicon 
microneedles were presented in [9] by Stoeber 
and Liepmann, while microneedles with 
biodegradable tips (mesoporous silicon) were 
reported in [10]. Other materials were explored as 
well: polysilicon [11], and even polymers [12, 
13]. Metal microneedles have also been targeted 
for transdermal drug delivery mainly due to their 
good mechanical properties and biocompatibility 
[14, 15].  In vitro and in vivo (on diabetic mice) 
studies demonstrate the delivery of insulin [16, 
17]. Lin et al [18] used microneedles to deliver 
20-mer phosphorothioated oligodeoxynucleotides 
across the skin of hairless guinea pigs. In [19] 
Matriano et al demonstrated the delivery of 
ovalbumin as a model protein coated onto a 
needle surface. Recently, “dissolving 
microneedles” were reported, i.e. microneedles 
which encapsulate the drug to be delivered and 
which slowly dissolve within the skin [20].  
Basically, the microneedles are fabricated by 
silicon with MEMS technologies. The various 
shapes and profiles of silicon microneedles, either 
hollow or solid needles, can be fabricated using 
the DRIE process [21-23]. 
978-1-4244-4413-7/09/$25.00 © 2009 IEEE
 204
 
Fig. 1. Microneedles can create pathways into the skin for 
drug delivery and are painless due to their size 
 
 
However, due to the high-aspect-ratio needle 
structure and fragility of silicon, these 
microneedles have some several shortcomings. 
The main problem of the silicon microneedles is 
that it breaks easily during the insertion process 
into the skin (Figure 2), and this increases the 
possibility of an infection. The solution proposed 
here is to fabricate the microneedles tip from a 
biodegradable porous silicon material. This 
porous silicon is well-known as nano-structured 
silicon and good for biological applications 
because of its bioactive and biodegradable 
properties [24-25]. The microneedles have been 
fabricated to have macro porous tips by using 
electrochemical etching process. These porous 
tips may break off after the drug delivery process 
and be allowed to remain in the skin, as it can be 




Fig. 2. SEM image showing the tip of a broken microneedle 
after insertion into a pig skin. 
 
 
Here we report the development of silicon 
microneedles array with biodegradable tips. The 
silicon microneedles array was fabricated by 
using notching effects of reactive ion etching 
(RIE). The macroporous tips were fabricated 
using a classical anodization process in 
MeCN/HF/H2O solution. The microneedles array 
was tested in vitro with an animal skin model by 
using a comparative study (bare skin diffusion 
and diffusion through the microneedle array). 
Calcein (molecular weight of 623 Da) and bovine 
serum albumin (BSA) - molecular weight of 
66.430 kDa were investigated in the drug 
delivery. The drug release profile was 
characterized using UV spectra detection, and the 
results showed that microneedles can enhance the 
calcein release rate by 5 times compared to 
conventional transdermal drug delivery methods 
without enhancers. Similarly, the enhancement 
factors of microneedle array for BSA were 7 
times compared to the bare diffusion rate. 
 
2. DESIGN  AND  FABRICATION 
 
The micro-sized needles are designed to 
penetrate the primary biological barrier of stratum 
corneum and the epidermis but without 
penetrating into the dermis layer that contains 
nerves and blood vessels, thus avoiding pain and 
bleeding. In our application, we chose to fabricate 
the microneedle arrays from silicon, making use 
of microfabrication techniques, mainly due to 
simplicity of the fabrication process. The 
microneedles are out-of-plane, 100 μm high, and 
arrayed in a 30 × 30 matrix on a 12 × 2 mm2 
silicon chip. Since the stratum corneum of skin 
has a depth of 10~20 μm, and epidermis has a 
variable depth of 50~100 μm, the penetrating 
length of the microneedles is preferred to be 
around 100 μm. 
Furthermore, in order to have an easy 
penetration into the skin, the microneedles should 
have a high aspect ratio. The fabrication of the 
microneedles was realized using an optimized 
SF6/O2 RIE process. By controlling the two gas 
flow rate, the microneedles were fabricated with 
an aspect ratio of 3:1 (height: width of the needle 
base) [26]. The isotropic profile of the 
microneedles was fabricated using two effects: 
flowing of thick photoresist mask and notching 
effect of the reflected charges on mask.  It is a 
well-known property of the thick photoresist that 
it reflows when it is heated at 120 °C [27]. The 
modification of the vertical wall of the patterned 
photoresist can reflect the charges (ions and 
radials) during the RIE process and in this way 
generates the etched profile under the oxide 
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mask. This phenomenon has also been reported 
for the Bosch process [28].  
 
 










Figure 3 is an example of the notching effect 
of reflected charges on the mask where ions and 
radicals with high energy are reflected by the 
oblique profile of the photoresist and generate an 
increased etching under the mask. The process 
eliminates the difficulty in the undercut control 
of the tips during the classical isotropic silicon 
etching process. Also, the end of the process can 
be very easily monitored using the video-camera 
of the “End Point Detection System” of the deep 
RIE tool. Once the required shape of the tip is 
achieved, the square shape of the mask is 
modified and we could observe the different 
rectangular shapes that correspond to the 
projection of the tiled square mask on the 
monitor. An SEM image that illustrates the 
released microneedles at the masking layer is 
presented in Fig. 4. 
The main steps of the fabrication process of the 
microneedles are presented in Fig. 5. A 4” silicon 
wafer with <100> crystallographic orientation, n- 
type 1~10 ohm-cm was initially cleaned in 
piranha solution (H2SO4: H2O2 = 2:1) at 120°C 
for 20 minutes and then rinsed in DI water and 
spun dried (Fig. 5a). On the silicon wafer a 0.5 
μm-thick SiO2 was deposited at 300°C, from 
SiH4 and N2O, at a pressure of 700 mTorr and a 
power of 300 W using STS-PECVD equipment 
(Fig. 5b). A photoresist mask using AZ9260 
positive photoresist (from Clariant), with a 
thickness of 8 μm, was used for the patterning of 
the SiO2-PECVD layer (Fig. 5c). The pattern is 
transferred to the SiO2 layer using a RIE etching 
system with CHF3: He gases on RIE dielectrics 
Adixen AMS100 (Figure 5d). After the patterning 
of the oxide layer, the tips were generated using 
an isotropic RIE process (Fig. 5e and 5f) with 
SF6/O2 in an ICP DRIE system. The process was 
optimized for a better control undercut, and with 
a depth-to-width aspect ratio of 3:1 [26]. A SEM 
image with the needles is presented in Fig. 6.  
 
 
Fig. 5. Fabrication process of nanotips: a) silicon wafer, b) 
PECVD SiO2, c) photoresist mask d) etching of SiO2, e) 





Fig. 6. SEM picture of the fabricate microneedle. 
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3. FABRICATION  PROCESS  OF  THE 
BIODEGRADABLE  TIPS 
After the fabrication of the silicon 
microneedles array, the following target was to 
develop an anodization process that allows the 
conversion of a single crystal silicon material of 
the tip into a porous structure. In order to achieve 
this, the “body” of the microneedles must be 
protected with a Si3N4 layer, releasing only the 
tip to be exposed during the anodization process. 
The main steps of the porous tips fabrication are 
shown in Fig. 7. 
  
Fig. 7. Fabrication process flow for the porous tips: (a) 
LPCVD Si3N4 deposition, (b) photoresist coating, (c) 
photoresist reflowing and O2 plasma, (d) Si3N4 etching in 
RIE and photoresist removal, (e) Al deposition (back of the 
wafer), (f) anodization. 
 
After cleaning, a 500 nm Si3N4 layer was 
deposited on the microneedles surface in PECVD 
reactor   [29, 30] (Figure 7a). With relatively 
good results, also PECVD SiC [31, 32] was can 
be used for the needles covering.  A thick layer of 
photoresist AZ9260 was spun twice on the 
surface of the microneedles, followed by baking 
at 120 °C for 15 min (Figure 7b). Due to the 
flowing effect, the photoresist covering the tips of 
the needles was much thinner than those at the 
body and at the bottom. Thus the photoresist on 
the tips of the microneedles was cleaned/removed 
in an O2 plasma etching process in RIE System 
(Fig. 7c). In this way only the top part of the 
needle is free of photoresist and the Si3N4 layer 
on the microneedle tips can be removed using a 
RIE process (CHF3/He chemistry) – Fig. 7d. The 
Si3N4 layer, from the backside of the wafer, was 
also removed using a similar RIE process. On the 
back of the wafer, an aluminum layer was 
sputtered in order to achieve a good electric 
contact for next electrochemical process (Fig. 7e). 
Then the porous silicon was generated only on 
the tip of the microneedle using a classical 
anodization process, while as the needle body 
was protected by the remaining Si3N4 layer (Fig. 
7f). Fig. 8 shows the experimental setup of the 
anodic electrochemical etching process [33]. The 
Pt electrode was used as the cathode and silicon 
wafer as anode. A DC power of 36~72 V was 
used as the source. The used electrolyte was a 
mixture of acetonitrile (MeCN) and diluted 
hydrofluoric acid (HF). The mixture has two 
compounds of MeCN : HF(4M) : H2O = 92% : 
4% : 4% by weight. The electrochemical 
anodization process was carried out at a current 
intensity of 10 mA·cm-2 for 30 min. Fig. 9 shows 
a SEM picture of the porous silicon tip after the 
anodization process.  
 




Fig. 9. SEM picture of the porous silicon tip. 
4. DRUG DELIVERY USING 
MICRONEEDLES ARRAY WITH 
BIODEGRADABLE TIPS  
4.1 Skin model 
The microneedle array was applied to the in 
vitro transdermal drug delivery model using pig 
skin. Pig skins were used in the experiment due 
to their similar physiological properties with the 
human skin. All animal procedures were 
performed in compliance with relevant 
regulations approved by the Institutional Animal 
Care and Use Committee of National University 
of Singapore. For the pig skins preparation, the 
skin were excised from the pig immediately after 
the pigs were sacrificed. The excised skins were 
fixed on top of plastic foam with the epidermis 
layer facing up. The adhering fat and other 
visceral debris in the skin were then carefully 
removed. The underlying subcutaneous fat was 
gently scraped off until the skin was about 1 mm 
thick. The prepared skins were washed, wrapped 
in aluminum foil, and stored at –80ºC. 
4.2 In vitro delivery testing setup 
A Franz diffusion cell (Logan Instruments 
Corp., Somerset, NJ) was used for the in vitro 
drug release. The pig skin was removed from the 
refrigeration chamber 1 hour before each 
experiment and mounted onto a Franz diffusion 
cell, with the stratum corneum side facing to the 
donor compartment. The microneedle array was 
then pressed onto the surface of the skin, and 
held by the donor compartment. The donor and 
receiver compartments were then clamped 
together. The receiver compartment was filled 
with phosphate buffered saline (PBS) solution 
while the temperature of water bath was 
maintained at 37°C. Figure 10 illustrates the 
experimental setup. For a better comparison, the 
drug release experiments were carried out in four 
parallel sessions: using passive diffusion through 
the skin, using the microneedles array.  
 
Fig. 10. Illustration of the in vitro transdermal delivery with 
the microneedles enhancer. 
 
4.3 Materials for testing 
The drugs tested in the experiments were 
calcein (at a concentration of 10-3 mol/l, or 623 
Da) and bovine serum albumin (BSA, molecular 
weight 66430 Da) with the concentration of 10-3 
mol/l. The permeability and transport of calcein 
across the skin was detected using UV-visible 
spectrophotometry (Agilent 8453 UV– vis 
system). The excitation wavelength of calcein 
was set to 480 nm. The same method was 
employed for BSA detection, but excitation 
wavelength in this case was 280 nm. 
4.4 Experimental results of calcein  
and BSA delivery 
 
Microneedles were inserted into the pig skin to 
generate conduits or microchannels for the 
transport of drugs across the stratum corneum. 
Once the delivery compound crosses the stratum 
corneum, it diffuses rapidly through the deeper 
tissue and is taken up by the underlying 
capillaries for systemic administration. The drug 
release profiles from the two kinds of transdermal 
delivery were compared and the results are shown 
in Fig. 11. The skin permeability of calcein was 
greatly enhanced to 5-6 times with microneedles, 
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compared to the passive transdermal delivery 
without microneedles. In other words, the total 
drug release with passive diffusion in 24 hours 
can be delivered in 7 hours with microneedles. 
Similarly, the drug release profiles from the two 
kinds of transdermal delivery were compared and 
the results are shown in Fig. 12. The skin 
permeability of BSA with microneedls was 
enhanced by ~7 times compared to the bare skin 
diffusion. This enhancement was attributed to the 
microchannels and pathways in the skin tissue 
created by the microneedles, which greatly 
increased the permeability of the skin.  

























Fig. 11. Calcein release profile with pig skin. 




























Fig. 12. BSA release profile with pig skin. 
5. CONCLUSIONS 
 
The microneedles array with biodegradable 
porous silicon tips for transdermal drug delivery 
was fabricated using micromachining 
technologies. The high aspect ratio of these 
needles was obtained with reflow of photoresist 
and the notching RIE process. The microneedle 
tips fabricated are macroporous and 
biodegradable and this is achieved by using the 
electrochemical anodization process. The 
transdermal drug delivery experiments showed 
that the microneedles can greatly enhance the 
skin permeability for better drug transport. The 
results indicate the feasibility of microneedles as 
a more effective transdermal drug delivery system 
with significant clinical potential. 
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